Xenetic Biosciences Inc (XBIO)
3.72
+0.17
(+4.79%)
USD |
NASDAQ |
May 17, 16:00
3.72
0.00 (0.00%)
After-Hours: 20:00
Xenetic Biosciences Profit Margin (Quarterly): -234.0% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -234.0% |
December 31, 2023 | -174.3% |
September 30, 2023 | -172.7% |
June 30, 2023 | -161.4% |
March 31, 2023 | -141.4% |
December 31, 2022 | -304.4% |
September 30, 2022 | -194.1% |
June 30, 2022 | -641.3% |
March 31, 2022 | -409.7% |
December 31, 2021 | -553.7% |
September 30, 2021 | -386.8% |
June 30, 2021 | -384.8% |
March 31, 2021 | -703.9% |
December 31, 2020 | -793.0% |
September 30, 2020 | -6.52K% |
June 30, 2020 | -844.5% |
March 31, 2020 | -2.08K% |
December 31, 2019 | -6.86K% |
September 30, 2019 | |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | 59.27% |
September 30, 2017 | -2.65K% |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | -13.04% |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
November 30, 2013 | -3.80K% |
August 31, 2013 | |
May 31, 2013 | -34.72% |
February 28, 2013 | 46.32% |
November 30, 2012 | -43.92% |
August 31, 2012 | -162.8% |
May 31, 2012 | -106.7% |
February 29, 2012 | -81.36% |
November 30, 2011 | -132.1% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.86K%
Minimum
Dec 2019
-141.4%
Maximum
Mar 2023
-1.20K%
Average
-398.2%
Median
Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Electromed Inc | 10.76% |
Xtant Medical Holdings Inc | -15.79% |
Asensus Surgical Inc | -2.00K% |
Myomo Inc | -102.2% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -41.34% |
Return on Assets | -38.28% |
Return on Invested Capital | -41.34% |
Operating Margin (Quarterly) | -248.3% |